BE871584A - Preparations pharmaceutiques - Google Patents

Preparations pharmaceutiques

Info

Publication number: BE871584A
Authority: BE; Belgium
Prior art keywords: pharmaceutical preparations; preparations; pharmaceutical
Prior art date: 1977-10-28

Application number

BE191383A

Other languages

English (en)

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1977-10-28

Filing date

1978-10-27

Publication date

1979-04-27

1978-05-19 Priority claimed from CH546678A external-priority patent/CH639846A5/de

1978-05-19 Priority claimed from CH546578A external-priority patent/CH642944A5/de

1978-09-07 Priority claimed from CH940778A external-priority patent/CH644850A5/de

1978-10-27 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

1979-04-27 Publication of BE871584A publication Critical patent/BE871584A/fr

Links

239000000825 pharmaceutical preparation Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/88—Nitrogen atoms, e.g. allantoin
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Emergency Medicine (AREA)
Engineering & Computer Science (AREA)
Tropical Medicine & Parasitology (AREA)
Bioinformatics & Cheminformatics (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Steroid Compounds (AREA)

BE191383A 1977-10-28 1978-10-27 Preparations pharmaceutiques BE871584A (fr)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
LU78407		1977-10-28
LU78408		1977-10-28
CH546678A CH639846A5 (en)	1978-05-19	1978-05-19	Pharmaceutical preparations having antiandrogenic action, containing urea derivatives or hydantoin derivatives
CH546578A CH642944A5 (en)	1978-05-19	1978-05-19	Urea derivatives
CH940778A CH644850A5 (en)	1977-10-28	1978-09-07	Pharmaceutical preparations containing urea derivatives

Publications (1)

Publication Number	Publication Date
BE871584A true BE871584A (fr)	1979-04-27

Family

ID=27509239

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE191383A BE871584A (fr)	1977-10-28	1978-10-27	Preparations pharmaceutiques

Country Status (15)

Country	Link
US (1)	US4234736A (fr)
JP (1)	JPS5473754A (fr)
AU (2)	AU522796B2 (fr)
BE (1)	BE871584A (fr)
BR (1)	BR7807115A (fr)
CA (2)	CA1138334A (fr)
DE (1)	DE2846945A1 (fr)
DK (1)	DK481778A (fr)
FR (1)	FR2407205A1 (fr)
GB (2)	GB2008101B (fr)
IL (1)	IL55774A (fr)
IT (1)	IT1100904B (fr)
NL (1)	NL7810562A (fr)
NZ (1)	NZ188720A (fr)
SE (2)	SE433304B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MC1220A1 (fr) *	1977-10-28	1979-07-20	Hoffmann La Roche	Nouveaux derives d'imidazolidine
FI801184A7 (fi) *	1979-04-24	1981-01-01	F Hoffmann La Roche & Co	Menetelmä imidatsolidiini-johdannaisten valmistamiseksi.
DE3382406D1 (de) *	1982-04-08	1991-10-17	Shell Int Research	Neue hydantoine, ihre herstellung und verwendung.
WO1990002112A1 (fr) *	1988-08-23	1990-03-08	The Nutrasweet Company	Arylurees substituees utilisees comme edulcorants de forte puissance
FR2656302B1 (fr) *	1989-12-22	1992-05-07	Roussel Uclaf	Nouveau procede de preparation de l'anandron et derives de l'anandron.
US5411981A (en) *	1991-01-09	1995-05-02	Roussel Uclaf	Phenylimidazolidines having antiandrogenic activity
USRE35956E (en) *	1991-01-09	1998-11-10	Roussel Uclaf	Phenylimidazolidines having antiandrogenic activity
FR2671348B1 (fr) *	1991-01-09	1993-03-26	Roussel Uclaf	Nouvelles phenylimidazolidines, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant.
US5670641A (en) *	1995-06-02	1997-09-23	American Cyanamid Company	3-(3-aryloxyphenyl)-1-(substituted methyl)-S-triazine-2,4,6-oxo or thiotrione herbicidal agents
US7001911B2 (en) *	2000-06-28	2006-02-21	Bristol-Myers Squibb Company	Fused cyclic modulators of nuclear hormone receptor function
JP2004509072A (ja) *	2000-06-28	2004-03-25	ブリストル−マイヤーズ　スクイブ　カンパニー	選択的アンドロゲン受容体モジュレーター並びにその同定、設計及び使用方法
US20040077605A1 (en)	2001-06-20	2004-04-22	Salvati Mark E.	Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
US6953679B2 (en)	2000-09-19	2005-10-11	Bristol-Myers Squibb Company	Method for the preparation of fused heterocyclic succinimide compounds and analogs thereof
EP1854798A3 (fr)	2000-09-19	2007-11-28	Bristol-Myers Squibb Company	Composés de succinimide hétérocyclique fondu et leurs analogies, modulateurs de la fonction de récepteur d'hormone nucléaire
US20040087548A1 (en)	2001-02-27	2004-05-06	Salvati Mark E.	Fused cyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
AU2002364082A1 (en)	2001-12-19	2003-07-09	Bristol-Myers Squibb Company	Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function
EP1709193B1 (fr) *	2003-12-19	2011-03-16	The Regents of The University of California	Procedes et materiaux pour evaluer des therapies du cancer de la prostate
WO2005099693A2 (fr) *	2004-02-24	2005-10-27	The Regents Of The University Of California	Methodes et substances permettant d'evaluer des therapies du cancer de la prostate, et composes s'y rapportant
US7709517B2 (en)	2005-05-13	2010-05-04	The Regents Of The University Of California	Diarylhydantoin compounds
ES2689292T3 (es)	2006-03-27	2018-11-13	The Regents Of The University Of California	Modulador del receptor de andrógenos para el tratamiento del cáncer de próstata y enfermedades asociadas con el receptor de andrógenos
NZ572374A (en)	2006-03-29	2011-12-22	Univ California	Diarylthiohydantoin compounds
EP2220050A2 (fr)	2007-10-26	2010-08-25	The Regents Of The University Of California	Composés de diarylhydantoïne
SG10201907588XA (en)	2010-02-16	2019-09-27	Aragon Pharmaceuticals Inc	Androgen Receptor Modulators And Uses Thereof
CN115737643A (zh)	2012-09-26	2023-03-07	阿拉贡药品公司	用于治疗非转移性去势抵抗性前列腺癌的抗雄激素
DK2945628T3 (da)	2013-01-15	2020-05-04	Aragon Pharmaceuticals Inc	Androgen receptormodulator i kombination med abirateronacetat og prednison til behandling af prostatacancer
TWI726969B (zh)	2016-01-11	2021-05-11	比利時商健生藥品公司	用作雄性激素受體拮抗劑之經取代之硫尿囊素衍生物
MX2020003845A (es)	2017-10-16	2020-11-06	Aragon Pharmaceuticals Inc	Antiandrógenos para el tratamiento de cáncer de próstata no metastásico resistente a la castración.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE629779A (fr) *
US3134663A (en) *	1957-07-23	1964-05-26	Geigy Chem Corp	Herbicidal composition and method employing hydantoins
GB997037A (en)	1962-03-19	1965-06-30	Ici Ltd	New hydrantoin derivatives
IL31416A0 (en)	1968-02-19	1969-03-27	Bayer Ag	5-imino-2-oxo-imidazolidines,their preparation and use as herbicides
NO124370B (fr) *	1968-03-28	1972-04-10	Ciba Geigy Ag
DK123717B (da) *	1968-11-25	1972-07-24	Sumitomo Chemical Co	3-(3',5'-Dihalogenphenyl)-imidazolidin-2,4-dionderivater med mirobicid virkning.
US3676456A (en) *	1970-02-27	1972-07-11	Ciba Geigy Corp	Derivatives of 3-aryl-5-alkylhydantoins
JPS5136332B1 (fr) *	1970-12-09	1976-10-07
US4044021A (en) *	1971-10-21	1977-08-23	American Cyanamid Company	Tetrasubstituted imidazolidine diuretics useful in the treatment of hyperaldosteronism
IL45459A (en)	1973-09-03	1978-01-31	Ciba Geigy Ag	1-(dichlorofluoromethylthio)-3-phenyl-imidazolidine-2,4-dione derivatives their preparation and their use as bactericides and fungicides
FR2329276A1 (fr)	1975-10-29	1977-05-27	Roussel Uclaf	Nouvelles imidazolidines substituees, procede de preparation, application comme medicament et compositions les renfermant

1978
- 1978-10-20 IL IL55774A patent/IL55774A/xx unknown
- 1978-10-20 CA CA000313827A patent/CA1138334A/fr not_active Expired
- 1978-10-23 AU AU40962/78A patent/AU522796B2/en not_active Expired
- 1978-10-23 NL NL7810562A patent/NL7810562A/xx not_active Application Discontinuation
- 1978-10-24 US US05/954,071 patent/US4234736A/en not_active Expired - Lifetime
- 1978-10-24 NZ NZ188720A patent/NZ188720A/en unknown
- 1978-10-25 FR FR7830328A patent/FR2407205A1/fr active Granted
- 1978-10-27 SE SE7811193A patent/SE433304B/xx not_active IP Right Cessation
- 1978-10-27 IT IT29207/78A patent/IT1100904B/it active
- 1978-10-27 BR BR7807115A patent/BR7807115A/pt unknown
- 1978-10-27 JP JP13177378A patent/JPS5473754A/ja active Pending
- 1978-10-27 DE DE19782846945 patent/DE2846945A1/de not_active Ceased
- 1978-10-27 GB GB7842246A patent/GB2008101B/en not_active Expired
- 1978-10-27 DK DK481778A patent/DK481778A/da not_active Application Discontinuation
- 1978-10-27 GB GB8118700A patent/GB2087870B/en not_active Expired
- 1978-10-27 BE BE191383A patent/BE871584A/fr not_active IP Right Cessation
1982
- 1982-03-02 AU AU81051/82A patent/AU551161B2/en not_active Expired
- 1982-04-01 SE SE8202106A patent/SE8202106L/xx not_active Application Discontinuation
- 1982-04-08 CA CA000400814A patent/CA1137091A/fr not_active Expired

Also Published As

Publication number	Publication date
GB2008101A (en)	1979-05-31
AU522796B2 (en)	1982-06-24
SE433304B (sv)	1984-05-21
FR2407205A1 (fr)	1979-05-25
DK481778A (da)	1979-04-29
CA1138334A (fr)	1982-12-28
AU8105182A (en)	1982-07-08
GB2087870A (en)	1982-06-03
IL55774A (en)	1982-04-30
FR2407205B1 (fr)	1982-12-31
AU551161B2 (en)	1986-04-17
US4234736A (en)	1980-11-18
JPS5473754A (en)	1979-06-13
SE8202106L (sv)	1982-04-01
DE2846945A1 (de)	1979-05-03
IT1100904B (it)	1985-09-28
CA1137091A (fr)	1982-12-07
GB2087870B (en)	1982-11-10
GB2008101B (en)	1982-09-08
IT7829207A0 (it)	1978-10-27
NZ188720A (en)	1984-12-14
IL55774A0 (en)	1978-12-17
BR7807115A (pt)	1979-05-15
AU4096278A (en)	1980-05-01
NL7810562A (nl)	1979-05-02
SE7811193L (sv)	1979-04-29

Legal Events

Date

Code

Title

Description

1988-04-30

RE

Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE & CIE S.A.

Effective date: 19871031

Publication	Publication Date	Title
NO801863L (no)	1980-12-22	Farmasoeytiske preparater.
SE7803527L (sv)	1978-10-01	Lekemedelsdosenhet
IT1100904B (it)	1985-09-28	Preparati farmaceutici
FI803767L (fi)	1981-06-29	Cortikosteroid innehaollande farmaceutiska blandningar
BE864359A (fr)	1978-08-28	Compositions pharmaceutiques antioestrogenes
SE7809373L (sv)	1979-03-07	Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
IT1095377B (it)	1985-08-10	Composizione farmaceutica
NL188645C (nl)	1992-08-17	1-azaxanthon-3-carbonzuurverbindingen en farmaceutische preparaten die deze verbindingen bevatten.
NL7806573A (nl)	1978-12-19	Preparaten met geneeskundige werkzaamheid.
NL7903769A (nl)	1979-11-19	Di-o-n-alkylglycerolderivaten en farmaceutische preparaten daarvan.
NL7801921A (nl)	1978-08-23	Farmaceutische preparaten.
BE863710A (nl)	1978-08-07	Pesticide-preparaten
NL7809626A (nl)	1979-03-23	Therapeutische preparaat.
FI802690A7 (fi)	1981-03-02	Dermatologiskt laekemedel
AT353973B (de)	1979-12-10	Kosmetischer wirkstoff
BE853569A (nl)	1977-10-14	Medicinale preparaten
FI783049A7 (fi)	1979-04-08	Farmaceutiskt aktiva(omega-aminoalkoxi)dibenzyler
DD128671A5 (de)	1977-11-30	Pharmazeutische mittel
NL184896C (nl)	1989-12-01	Pyranochinolinonderivaten en gevormde farmaceutische preparaten die deze bevatten.
NL7805158A (nl)	1978-11-16	Farmaceutisch preparaat.
SE7600480L (sv)	1976-07-21	Farmaceutiskt anvendbara 2-aminoacetamido-alfa-fenylbensylidenaminoalk
NL7812344A (nl)	1979-06-26	Farmaceutisch preparaat.
BE848975A (fr)	1977-06-02	Preparations pharmaceutiques contraceptive
NL7803601A (nl)	1978-10-20	Farmaceutische preparaten.
SE8000268L (sv)	1980-07-23	Farmaceutiska beredningar